<DOC>
	<DOC>NCT02443519</DOC>
	<brief_summary>This randomized clinical trial aims to examine the effect of a standardized 8-week course of Mindfulness Based Cognitive Therapy for Migraine on migraine-related disability in people with migraine.</brief_summary>
	<brief_title>Bronx MBCT-Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>ICHD3 beta headache diagnosis of migraine, selfreported and diaryconfirmed 420 headache days per month aged 1865 ability to read English capacity to consent. no ICHD3 beta headache diagnosis of migraine fewer than 4 or greater than 20 headache days per month under 18 or over 65 inability to read English lacking the capacity to consent utilization of new preventative pain treatments within four weeks of the baseline assessment, or a plan to utilize new preventive pain medications during the duration of the study severe psychiatric illness that would interfere with participation in the treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Mindfulness</keyword>
	<keyword>MBCT</keyword>
	<keyword>Cognitive Therapy</keyword>
	<keyword>Disability</keyword>
</DOC>